Cardiomyocytes are the single nucleus cylindrical and elliptical cells of the heart measuring 80–120 µm in length and 20–30 µm in diameter. Cardiomyocytes have a limited capacity to regenerate. The lost cardiomyocytes are replaced by fibroblasts and myofibroblasts which form scar tissues. The formation of these non?contracting fibrous scars alters the workload of the myocardium and results in congestive Heart Failure (HF), which has serious implications on the patient in terms of life expectancy, and further causes hypertension, coronary artery disease, and myocardial infarction (heart attack). Hence, the regeneration of the myocardium is essential for the survival of patients. Cardiac patches are heart repair products that incorporate human cells to replace damaged heart tissue. The cardiac patch contracts and expands like a normal human heart tissue and is developed by tissue engineering approach which creates three-dimensional porous scaffolds to create functional cardiac patches for transfer of exogenous cells.
Read Report Overview - https://www.transparencymarketresearch.com/cardiac-patch-market.html
Cardiac patch, which is a suitable alternative to heart transplant, recovers the heart tissue and ensures its sound functioning. The integration of advanced features such as therapeutic control through drug release is another groundbreaking innovation which is expected to be introduced in the cardiac patches and marketed globally in the coming decade. Such improvisations and additional features to the existing cardiac patches is anticipated to fuel the growth of the global cardiac patch market significantly during the 2017-2025 period. However, the limitations of cardiac patches such as the formation of aneurysms and the obstruction of growth potential because of ingrown tissue and calcification leads to multiple replacements and can hamper the market growth.
The global cardiac patch market can be segmented based on end-users and region. In terms of end-users, the market can be divided into hospitals and specialty clinics. The hospitals segment is likely to hold a major share in the global cardiac patch market owing to higher number of procedures performed in hospitals and its continued rise each year. The hospitals segment is likely to continue to dominate the market during the forecast period owing to the availability of novel surgical procedures in these settings. Additionally, the number of hospitals is higher than other healthcare facilities/providers across the globe, especially in low- and middle-income countries.
Request Brochure –
https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=39380
In terms of region, the global cardiac patch market can be segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America and Europe are expected to dominate and account for more than half the share of the global market through 2017 to 2025, owing to factors such as higher prevalence of heart disorders as compared to other countries coupled with high per capita healthcare expenditure and product availability. Cardiovascular diseases (CVDs) are listed as a major cause of mortality across the world, and are also responsible for one in every three deaths in the U.S. According to the American Heart Association, 45% of all the deaths in the U.S. occurred due to heart diseases each year, and an estimated 92.1 million people in the U.S. were living with cardiovascular diseases in 2016.
The global cardiac patch market has few players currently but would witness market entry of some startups. The major players operating in the global cardiac patch market are W. L. Gore & Associates, BARD Peripheral Vascular, MAQUET Holding B.V. & Co. KG, and Taewoong Medical Co., Ltd. among others.
Request COVID Analysis on Cardiac Patch Market –
https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19&rep_id=39380
This study by TMR is all-encompassing framework of the dynamics of the market. It mainly comprises critical assessment of consumers' or customers' journeys, current and emerging avenues, and strategic framework to enable CXOs take effective decisions.
Our key underpinning is the 4-Quadrant Framework EIRS that offers detailed visualization of four elements:
- Customer Experience Maps
- Insights and Tools based on data-driven research
- Actionable Results to meet all the business priorities
- Strategic Frameworks to boost the growth journey
The study strives to evaluate the current and future growth prospects, untapped avenues, factors shaping their revenue potential, and demand and consumption patterns in the global market by breaking it into region-wise assessment.
Request Customization on Cardiac Patch Market Report –
https://www.transparencymarketresearch.com/sample/sample.php?flag=CR&rep_id=39380
The following regional segments are covered comprehensively:
- North America
- Asia Pacific
- Europe
- Latin America
- The Middle East and Africa
The EIRS quadrant framework in the report sums up our wide spectrum of data-driven research and advisory for CXOs to help them make better decisions for their businesses and stay as leaders.
Aug 09, 2019 (AB Digital via COMTEX) -- Market Trends
The global Cardiac Rehabilitation Devices Market is projected to reach over USD 2,839.9 million by 2023 at 6.2% CAGR during the review period of 2018 to 2023.
Cardiac rehabilitation is a medically managed program designed to improve cardiovascular health.
The rising prevalence of cardiac diseases, adoption of an unhealthy lifestyle and increasing geriatric population are driving the growth of the global cardiac rehabilitation devices market.
However, the factor such as the high cost of cardiac rehabilitation devices and stringent government regulations hinders market growth.
Cardiac Rehabilitation Devices Market Leading Companies:
